Get started

Coronavirus (COVID-19)

🔀 Bang Bang. Zoom Hit The Ground. Bang Bang. Bears Shot It DownZoom company's video-conferencing service became so ubiquitous during the Covid-19 pandemic that its corporate name became a verb describing the act of firing up a video chat to connect with coworkers online. Zoom shares VIE:ZOOM rose seven-fold in 2020 as sales surged after millions of workers were stuck at home because of COVID-19 restrictions. By 2021, though, revenue growth slowed, and the stock plunged. The company has shed at least $100 billion in market value since then. Meanwhile over the past two years, the stock has stagnated because Zoom's video-conferencing service is needed less as businesses continue pushing staff back to the office. Zoom, one of the main enablers and beneficiaries of remote work, in August 2023 has asked its employees to head back to the office. The company announced that employees living within 50 miles of a Zoom office must work there at least two days a week. "We believe that a structured hybrid approach – meaning employees that live near an office need to be onsite two days a week to interact with their teams – is most effective for Zoom," a spokesperson said in a statement. "As a company, we are in a better position to use our own technologies, continue to innovate, and support our global customers." As pandemic Covid-19 is over, many other companies have announced return-to-office mandates, but Zoom's change of heart is surprising given the role its technology plays in remote work. The company's video-conferencing service became so ubiquitous during the pandemic that its corporate name became a verb describing the act of firing up a video chat to connect with coworkers online. People are back to Travelling. The annual graph for NYSE:RPM , Revenue Passenger Miles for U.S. Air Carrier Domestic and International, Scheduled Passenger Flights. Meanwhile, there're some important things to say. Warren Buffett's 99-year-old business partner, Charlie Munger, was surprisingly embraced Zoom during the pandemic. Eric Yuan, the founder and CEO of the video-conferencing platform, celebrated the veteran investor's endorsement of his product on an earnings in 2021. "I have fallen in love with Zoom," Munger, the vice-chairman of Berkshire Hathaway, said in a CNBC interview filmed at Berkshire's annual shareholder meeting in May, 2021. "Zoom is here to stay. It just adds so much convenience." • Munger added that he struck a deal in Australia using the communications tool. He trumpeted its prospects at Daily Journal's annual meeting in February, 2021 as well. • When the pandemic is over, I don't think we're going back to just the way things were," the newspaper publisher's chairman said. • We're going to do a lot less travel and a lot more Zooming. Charlie loves Zoom and uses it frequently for business and to keep in touch with his family, as it's difficult for him to travel. His business advice was to build a better product or offer a better solution, that it's all about competition, and that successful people are those with the acumen to understand life better than everyone else. He said it's up to you to work harder and better than the next person. Charlie also said investments are better than money in the bank, and it's important to go to the office to work in person. The main graph says, Zoom equities just hit the major all history ground support near $59 per share.
NASDAQ:ZM
by Pandorra
You Are a Puppet - How The Elite is Manipulating the MarketsWelcome back Future Demons Let me make it very clear. I’m here to help you become a better trader, and make money. I’m not a fan of Wall Street, the Elite, the big asset management companies like BlackRock, Vanguard who own most of the biggest companies in the world. They are known for manipulating the markets, to bait you in, and take advantage of you. They are ruthless. They have secret collabs with journalists around the world from big mainstream media, who will trick you with clickbait articles. But there is way more.. Also there is a big misconception, that the big American asset management companies only hold Western stocks. No, my friend. They hold Russian and Chinese stocks as well. They try to disguise it of course via shadow companies and banks. The Elite in USA, Europe, Russia and China are all "working together", and all have part in the world’s biggest companies and share the same goal. More money and more power. This is NOT a war between sides - East vs West - as they will portrait it in the mainstream media. They have and will continue to brainwash you to believe in this narrative, while they are making money, and the people are dying in war. This is in reality a war between up and down. The elite vs the people. Historically it has always been like that. The church vs the illiterate people. The Kingdom vs the peasents. And there is no difference this time. —— Why am I telling you this? We haven’t seen a bear market in 15 years, which is unheard of. We have been very close many times, but suddenly came COVID, which made the markets blossom again. The small businesses went bankrupt, while the giants made money again. After some time we saw a decline again. Russia invaded Ukraine, and USA (NATO), didn’t try to stop the war. They rejected any kind of diplomatic negotiations. Why? Obviously because they knew, that especially a proxy-war is good for the markets. All the weapons US has sold to Ukraine, made the markets recover. Then again very conveniently Israel had an excuse to use their power against Palestine, which meant more war-money, and again the market managed to recover. The recent little trick is now the 600,000 polio-vaccines UN will give to the Palestinian kids, who are suffering in Gaza. There is catch though, that many is not aware of. The polio vaccine is made by a French company Sanofi. It only takes a Google search or 2 to find out, who the biggest investor is: Dodge Cox, owned by Johnson, Wells Fargo, Alphabet (Google), Microsoft and more. Last but not least, let me also state, that the AI hype lately has been the main reason the markets has increased. But with this post I just want to make it clear, that the Elite, the Deep State, whatever you want to call them, will do whatever it takes to make money. And they are ruthless. What to do now? If you are out of the markets, stay out! If you are in the markets secure profit. We have no idea how high we will go, but there is no doubt imo, that this is a huge bubble, and we will most likely soon go into a Depression like we did 100 years ago in the 1930s. War has historically always been the last instrument before a crash. Kind Regards LaPlaces Demon PS. I know that some people might disagree with my analysis, which is totally ok. What I have learnt the last 10 years trading is to follow the money. And market psychology is my biggest strength.
SP:SPXShort
by Lapl4cesDem0n
10
AIRBUS READY FOR TAKEOFF - 65% PROFITAIRBUS (AIR) - 4hr/Frankfurt Hello and welcome to this update, this one is about Airbus, which looks GOOD in my opinion. -All-time high was 140, which we dropped from, which is a 65% drop. -RSI looking good, bullish divergence confirmed. -Volume is solid- declining at the bottom (or temporary bottom) is a good sign and could mean, the selloff came to an end (for now). -Reversal of 65% to 79€ (Resistance from 2nd January 2019) from 48€ is absolutely in range. -Contesting all-time high in the future is possible as well since Airbus is next to Boeing the biggest aircraft and flight producer in the market. -Longterm, this is a steal in my opinion. Since we are in "reporting Season", end of April there will be the quarterly report of Airbus, which could stagnate, due to the corona crisis and the circumstances, which many companies suffer from. Aviation Business could be under pressure, though for the longterm, this will be fine in my opinion. Have a nice day, thank you for tuning in, I appreciate it a lot! Your german-quality-trader
XETR:AIRLong
by GER-Quality-Trades
2
Novavax Surge Over 130% On $1.4 Bln Covid Shot Deal with SanofiNovavax shares ( NASDAQ:NVAX ) surged over 130% after a $1.4 billion deal with Sanofi was announced to commercialize its Covid vaccine and develop a new combination shot for protecting against the flu and Covid. The biotech firm announced a licensing agreement with Sanofi to sell Novavax’s Covid vaccine worldwide, with Sanofi paying Novavax $500 million upfront and future payments up to $700 million based on other milestones, in addition to royalties. Sanofi will receive a sole license to develop and commercialize a combination flu and Covid vaccine containing Novavax’s Covid shot and Sanofi’s flu shot. Novavax ( NASDAQ:NVAX ) is also entitled to launch and sales milestones of up to $200 million for any vaccine developed by Sanofi as part of the deal. The company expects to launch a late-stage trial of its own combination vaccine targeting Covid and the flu and a stand-alone flu shot later this year. The licensing agreement will likely lift Novavax’s “going concern” warning issued last year, after the company said “substantial doubt exists” to continue operating. A significant uptick for Novavax ( NASDAQ:NVAX ) shares follows yearslong financial woes for the biotech firm. The company cut its 2024 sales forecast in its first-quarter review, decreasing projections from between $800 million and $1 billion to $400 million to $600 million. Novavax ( NASDAQ:NVAX ) also reported a first-quarter net loss of $148 million, compared with a net loss of $294 million during the same period last year. As part of the deal, Sanofi is also taking a less than 5% equity stake in Novavax, and Novavax ( NASDAQ:NVAX ) will receive royalty payments for future sales of its COVID-19 vaccine and the future combination COVID-19 and flu vaccine. The deal will allow Novavax to lift its “going concern” warning, which was issued in early 2023 over concerns that it may not be able to financially survive as demand for COVID-19 vaccines waned. Alongside the Sanofi deal, Novavax ( NASDAQ:NVAX ) also reported first-quarter results that missed analyst estimates. Novavax ( NASDAQ:NVAX ) reported revenue for the first quarter of $93.9 million, shy of the $101.3 million analysts expected, and posted a loss of $147.6 million, or $1.05 per share, wider than the loss of $127.4 million, or 90 cents per share, that analysts projected. For the full fiscal year, Novavax ( NASDAQ:NVAX ) lowered its projected revenue to $400 million to $600 million, down from the previous range of $800 million to $1 billion. However, the estimated $570 million the company expects to receive from Sanofi this year pushed its combined revenue and payments projections higher, to $970 million to $1.17 billion. Technical Outlook Novavax ( NASDAQ:NVAX ) is up 98% as of the time of writing, trading above the 200-day Moving Average (MA). The stock has a Relative Strength Index (RSI) of 86.66 which is clearly in an overbought territory. The daily price charts depict an upside or upward gap that occurred as a result of the impending deal.
NASDAQ:NVAXLong
by DEXWireNews
1
30 YEARS OF DAXHello there, let´s keep this short! I observed higher lows, while the Relative strength of the market shows Higher Low´s as well! This is actually a good sign and looking through my binocular, the coming decade looks pretty bright to me! We have a huge dip of 35%, triggered by the corona virus covid-19. The financial crisis is here and it harms economy, global logistic und production foundation. Therefore producers won´t sell their stuff, people won´t buy and the goverments will earn less taxes, which results in public turmoil! We will manage this as societies, but hard times in the short term (coming months and years). Anyway, technically this recovery mode is neccesarry, since we note a huge Bullmarket since the 2008/09 crash! Higher Lows while RSI shows higher Lows as well, which is-technically seen- a bullish sign!
XETR:DAX
by GER-Quality-Trades
1
GLOBAL ECONOMY - FORECAST Hello there dear traders, this is a quick update on DJI. I just noticed a bullish divergence on the daily RSI (Relative strength of the market) which could lead a bounce back towards all-time high, which we just hit a few weeks ago. Since Corona caused problems to the markets (more likely a bloodbath), people are panicking and overselling their holdings. The most absurd stuff was the shrinking of Anheuser-Busch stock, which is the owner of Corona-Beer, a beer and beverage company, which notes massives losses due to the situation decreasing sales... Anyway, in my opinion markets are oversold right now and there is a chance we might see a bounce back up to <<<28600!>>> RSI looking good and news are still bearish- for me time to fill my bags! If you are interested in what I buy, make sure to ask in the comment section for a specific stock or index, I will tell you my opinion/create a chart for that! If it works out and we come close to the previous all-time high, we will possibly retest this low as of today and at that point we will compare to RSI again and decide what to do! <<<<23100>>>> Note: If we make lower lows and the strength of the DJI lowers as well, trades are canceled!
TVC:DJILong
by GER-Quality-Trades
MCK a large cap medical supply company LONGMCK is a large cap medical supply company- it has experienced respectable earnings reports and steady growth as medical entities including surgery centers and hospitals are busy catching up on electric surgeries from the COVID era. It is rising ar or under the second upper VWAP line. The dual time frame RSI indicator ( by Chris Moody) shows that every time the faster RSI ( 1 hour) RSI drops down to the 50 level it rebounds with a corresponding price move up. These episodes are shown as thin black vertical lines. One of them is at present. The forecasting algorithm of Lux Algo predicts a further rise to the level of 575 in the next six weeks. The last earnings was quite solid with the next earnings in 4 weeks. I will take a long trade here. I will add to the position for any dips to or below the running EMA 9 but not reaching the EMA100. I will take a partial profit at 560 and cut the position down to 25% the day before earnings for purposes of good risk management. If price crosses under the running EMA100 I will close the trade and collect the unrealized profit.
NYSE:MCK
by AwesomeAvani
Moderna's Surprising Profit Signals Post-Pandemic PivotModerna ( NASDAQ:MRNA ), the pioneering vaccine maker, reported a surprise fourth-quarter profit, sending ripples of optimism through the market. Bolstered by unexpected revenue and strategic cost-cutting measures, the company's resilience amid shifting tides in the pharmaceutical landscape has drawn both attention and applause. Unveiling the Numbers: Moderna's ( NASDAQ:MRNA ) fourth-quarter profit stood at a commendable $217 million, or 55 cents a share, defying analyst expectations of a substantial loss. This unexpected triumph was fueled by a combination of factors, including unforeseen deferred revenue and a strategic overhaul in manufacturing operations. The company's ability to navigate challenges and adapt swiftly underscores its agility and forward-thinking approach. Navigating the COVID-19 Landscape: While Moderna's COVID-19 vaccine continues to be its flagship product, generating substantial revenue, the company is strategically diversifying its portfolio. Despite a decline in COVID vaccine sales from 2022 to 2023, Moderna ( NASDAQ:MRNA ) remains steadfast in its commitment to innovation. The imminent approval decision for its respiratory syncytial virus (RSV) shot marks a significant milestone in this diversification strategy, offering a glimpse into the company's post-pandemic roadmap. Looking Beyond COVID: Moderna's ( NASDAQ:MRNA ) ambitious roadmap extends far beyond the realm of COVID-19. With plans to launch its RSV shot in key markets and a robust pipeline of experimental shots targeting influenza, cancer, and cytomegalovirus, the company is poised for a transformative journey. Despite concerns over efficacy declines compared to rival offerings, Moderna's ( NASDAQ:MRNA ) unwavering focus on research and development signals a bold leap into uncharted territories. International Endeavors: Moderna's ( NASDAQ:MRNA ) participation in the EU Health Emergency and Response Authority’s tendering procedure underscores its commitment to global health initiatives. By prioritizing key international markets and aligning with strategic partners, the company aims to broaden its reach and impact. The forthcoming decision on the EU tender is poised to shape the company's trajectory in the global arena, setting the stage for future collaborations and expansions. Charting the Course Ahead: As Moderna ( NASDAQ:MRNA ) reaffirms its 2024 forecast amidst shifting market dynamics, the company remains steadfast in its pursuit of excellence. With a projected $4 billion in sales and a focus on operational execution, Moderna ( NASDAQ:MRNA ) is poised to navigate challenges and seize opportunities in the years ahead. Conclusion: Moderna's ( NASDAQ:MRNA ) unexpected profit surge and strategic roadmap offer a compelling narrative of resilience and innovation in a rapidly evolving landscape. With eyes set on new horizons and a steadfast resolve, Moderna ( NASDAQ:MRNA ) emerges as a beacon of hope in the post-pandemic world.
NASDAQ:MRNALong
by DEXWireNews
S&P500 in 2020 & 2024. OR ARE YOU READY FOR A NEW ONE SKYFALL!?Due to recent publications by TradingView Team and many other TradingViewers I wonder, how strong people still believe in 4-years inflation/ disinflation credit cycle, with their eternal BTC-to-the-Moon expectations. Okkkay, Google. Let it be.. Let it be... Each coin has two sides. Just remembered, how many Covid19-talking people were there in the room a couple months before it's happened in early 2020. The main graph is comparison between SP500 4 years ago and in nowadays. Similar, or not? - Time will show! // This is the end Hold your breath and count to ten Feel the Earth move and then Hear my heart burst again For this is the end I've drowned and dreamt this moment So overdue, I owe them Swept away, I'm stolen Let the sky fall When it crumbles We will stand tall Face it all together Let the sky fall When it crumbles We will stand tall Face it all together At Skyfall At Skyfall // Not an investment advice
CME_MINI:ES1!
by Pandorra
Decoding the Mystery Behind Dec 20 Fall - Part 77. Nifty Auto -2.28% 3 Months - Rounding Bottom BO done. Target 19752 - nothing wrong in 3 Months / Monthly scale - its going up and wick is getting formed once in a while Weekly - as you can see at every step - there is a Horizontal Consolidation (BOX Pattern) for some weeks then BO, again BOX BO and repeat..... When the stock / sector has a crossed ATH and goes up - there is no more resistance it push it down. But it writes its own fate by creating new Support & Resistances once again because of People's Greed & Fear. When majority thinks it has grown too much - they sell off causing a temp dip. As you can see - there are bigger Red candles in Weekly history. Absolutely nothing wrong - and Still in the Bullish pattern - no negation of pattern anywhere. Trendline Support is also an additional support
NSE:CNXAUTO
by Stocks-n-Trends
Decoding the Mystery Behind Dec 20 Fall - Part 66. Nifty Realty -2.43% 3 Months / Monthly - Beautiful Rounding Bottom structure - BO also done already @ 3M scale Weekly - Upward Parallel Channel Structure with a Confluence of 3 Months Resistance @ 755 acting together. Double Resistance - Double Strong Analysis and a big fall today Its not your FII friends / Covid Virus / Christmas Santa pushing these sectors down. On a normal day when any stock / sector faces a Resistance - it is bound to Fall - that's like an Open Secret. This is exactly what happened today. So Why so much Hangama ??
NSE:CNXREALTY
by Stocks-n-Trends
Decoding the Mystery Behind the Dec 20 Fall - Part 55. Nifty Energy -2.68% fall 3Months / Monthly - After a steep rise initially - the sector has reduced the angle of growth - forming an upward parallel Channel with an Embedded Flag Pattern - BO is also done 6 months back Weekly - Precise Rejection from the Long Term Trendline Resistance. See how beautifully it touches the top of the Green candle and cuts thru this week's Red. Remember one thing - when each sector faces their Resistance separately the fall is smaller. But when ALL Sectors face their resistances together on same day - the Fall usually is significant. Because this is how big players Orchestrate the fall and due to this "Repeated Human Behavior" the Chart pattern becomes "Predictable and Repeatable"
NSE:CNXENERGY
by Stocks-n-Trends
Decoding the Mystery Behind Dec 20 Fall - Part 44. Nifty Mid Cap 100 -3.27% Monthly - Upward Channel with Fib Golden Ratio 0.618 retracement - 1.618 extension Target given was 41,346. Target Met & Exceeded Weekly - Look at 1.618 level crossing and a minor correction caused by it. See how precise Technical Analysis work. Once a target is reached usually we find a retracement after testing that level Similar to small cap - after the BO of upward Parallel channel / wedge - the customary Retest process is initiated. Same as small cap - as of today - it's an Bearish engulfing candle - but have to wait for weekly close to see. Irrespective of the size of candle - once a retest begins - it just happens - whether its faster or slower does not matter. next support at 41302
NSE:CNXMIDCAP
by Stocks-n-Trends
Decoding the Mystery Behind Dec 20 Fall - Part 33. Nifty Small Cap 100 - 3rd highest fall today - 3.63% Monthly - Upward Parallel Channel BO + Cup & Handle BO confirmed at Monthly as of Nov Weekly - The Customary BO Retest process in progress. Today's fall has formed a Bearish Engulfing Candle, but only by weekly close we can confirm if it is still an Engulfing Candle or a smaller one with a wick at bottom. Folks in IT / Agile process would use the term "Definition of Done.....which says "Anything is not Done until its fully complete" - So wait for the weekly close to derive the real story
NSE:CNXSMALLCAP
by Stocks-n-Trends
Decoding the Mystery behind Dec 20 Fall - Part 11. Nifty Media - the Biggest Fall among its Peers (-5.11%) - Comparison between Monthly & Weekly Chart Month - Beautiful Cup & Handle Pattern - BO attempted today but didn't sustain (no change in pattern) Week - Inside the Handle - there is an Inv. H&S pattern - Look at the rejection today from BO + Resistance zone of 2500 Neither is this the Biggest Weekly fall (as per weekly chart) nor does it negate the current Bullish Pattern. After 2-3 months when you see the weekly chart - does it really matter whether it fell 5% in 1 day or 5% in total across the entire week ? no one cares. So why so much noise ?
C
by Stocks-n-Trends